Breaking News, Promotions & Moves

Vernal Biosciences Appoints New CEO

Jim Petrilla succeeds founding CEO Christian Cobaugh.

Author Image

By: Charlie Sternberg

Associate Editor

Vernal Biosciences Inc., a leader in mRNA and lipid nanoparticle (LNP) development, manufacturing, and analytics, has appointed Jim Petrilla as Chief Executive Officer (CEO) and Board Director.   Petrilla succeeds founding CEO Christian Cobaugh, Ph.D., who will continue with the company as Chief Scientific Officer (CSO) and Board Director, focusing on advancing Vernal’s scientific and technological capabilities to further excellence in innovation.   “We are thrilled to welcome Jim to Vernal ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters